Company:  ATYR PHARMA INC (LIFE)
Form Type:  424B5
Filing Date:  5/20/2020 
CIK:  0001339970 
Address:  3545 JOHN HOPKINS COURT, STE #250 
City, State, Zip:  SAN DIEGO, California 92121 
Telephone:  858-731-8389 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$4.31  
Change: 
0.09 (2.13%)  
Trade Time: 
Sep 18  
Market Cap: 
$42.85M
Trade LIFE now with

© 2020  
Description of Business
We are a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways. We have concentrated our research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Built on more than a decade of foundational science on extracellular tRNA synthetase biology and its effect on immune responses, we have built a global intellectual property estate directed to a potential pipeline of protein compositions derived from 20 tRNA synthetase genes and their extracellular targets, such as neuropilin-2 (NRP2). Our primary focus is on ATYR1923, a clinical stage product candidate which binds to the NRP2 receptor and is designed to down regulate immune engagement in interstitial lung diseases (ILDs).
Register and access this filing in:     
  FORM 424B5
    TABLE OF CONTENTS
      INCOME STATEMENT
    ABOUT THIS PROSPECTUS SUPPLEMENT
    THE OFFERING
    RISK FACTORS
    CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
    USE OF PROCEEDS
    DIVIDEND POLICY
    DILUTION
    PLAN OF DISTRIBUTION
    LEGAL MATTERS
    EXPERTS
    WHERE YOU CAN FIND MORE INFORMATION
    RISK FACTORS
    RATIO OF EARNINGS TO FIXED CHARGES
    USE OF PROCEEDS
    DESCRIPTION OF CAPITAL STOCK
    Transfer Agent and Registrar
    DESCRIPTION OF DEBT SECURITIES
    DESCRIPTION OF WARRANTS
    DESCRIPTION OF UNITS